INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Bericht
Verzögert Nasdaq  -  22:00 18.08.2022
50.74 USD   -1.48%
15.08.INSIDERVERKAUF : Intrazelluläre Therapien
MT
11.08.INTRA-CELLULAR THERAPIES, INC. : Bewertung von Mizuho Securities zum Kaufen erhalten
MM
10.08.INTRA-CELLULAR THERAPIES, INC. : Bewertung von Needham & Co. zum Kaufen erhalten
MM
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über INTRA-CELLULAR THERAPIES, INC.
15.08.INSIDER SELL : Intra-Cellular Therapies
09.08.INTRA CELLULAR THERAPIES : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORP..
09.08.TRANSCRIPT : Intra-Cellular Therapies, Inc., Q2 2022 Earnings Call, Aug 09, 2022
09.08.Intra-Cellular Therapies Q2 Net Loss Widens, Revenue Climbs
09.08.INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
09.08.INTRA-CELLULAR : Q2 Earnings Snapshot
09.08.INTRA-CELLULAR THERAPIES, INC. : Results of Operations and Financial Condition, Other Even..
09.08.Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Cor..
09.08.Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q2 Revenue $55.6M
09.08.Intra-Cellular Therapies, Inc. Reports Earnings Results for the Second Quarter and Six ..
02.08.Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call ..
13.06.INTRA-CELLULAR THERAPIES, INC. : Submission of Matters to a Vote of Security Holders (form..
13.06.Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations ..
10.05.SECTOR UPDATE : Health Care Stocks Carried Higher by Surging Biotechs
10.05.SECTOR UPDATE : Health Care Stocks Still Edging Higher This Afternoon
10.05.Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises; Shares Rise Tuesday Afternoon
10.05.Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises
10.05.TRANSCRIPT : Intra-Cellular Therapies, Inc., Q1 2022 Earnings Call, May 10, 2022
10.05.INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
10.05.Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $35M
10.05.INTRA-CELLULAR : Q1 Earnings Snapshot
10.05.INTRA-CELLULAR THERAPIES, INC. : Results of Operations and Financial Condition, Other Even..
10.05.Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corp..
10.05.Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended Mar..
03.05.Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call a..
26.04.Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA (lu..
25.04.Intra-Cellular Therapies Says FDA Approves Two New Dosage Strengths for Treatment of Sc..
25.04.INTRA CELLULAR THERAPIES : Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lu..
25.04.INTRA-CELLULAR THERAPIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K..
25.04.Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (l..
25.04.Intra-Cellular Therapies, Inc. Announces FDA Approval of New Dosage Strengths for CAPLY..
21.04.INTRA CELLULAR THERAPIES : Announces Appointment of E. Rene Salas to Board of Directors - ..
21.04.INTRA-CELLULAR THERAPIES, INC. : Change in Directors or Principal Officers, Financial Stat..
21.04.Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
21.04.Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors a..
11.04.INSIDER SELL : Intra-Cellular Therapies
05.04.Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Confe..
21.03.INSIDER SELL : Intra-Cellular Therapies
06.03.Certain Option of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreement End..
06.03.Certain Common Stock of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreeme..
06.03.Certain Restricted Stock Unit of Intra-Cellular Therapies, Inc. are subject to a Lock-U..
01.03.TRANSCRIPT : Intra-Cellular Therapies, Inc., Q4 2021 Earnings Call, Mar 01, 2022
01.03.Intra-Cellular Therapies Widens Q4 Net Loss as Revenue Doubles
01.03.INTRA CELLULAR THERAPIES : REPORTS FOURTH QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS AND..
01.03.INTRA-CELLULAR THERAPIES, INC. : Results of Operations and Financial Condition, Other Even..
01.03.Intra-Cellular Therapies, Inc. Reports Earnings Results for the Fourth Quarter Ended De..
01.03.INTRA-CELLULAR : Q4 Earnings Snapshot
01.03.INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
01.03.Intra-Cellular Therapies, Inc. Reports Earnings Results for the Full Year Ended Decembe..
01.03.Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q4 Revenue $25.7M
01.03.Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results an..
24.02.INSIDER SELL : Intra-Cellular Therapies
22.02.Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Co..
10.02.Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Co..
12.01.INSIDER SELL : Intra-Cellular Therapies
10.01.Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
10.01.TRANSCRIPT : Intra-Cellular Therapies, Inc. Presents at JPMorgan 40th Annual Healthcare Co..
07.01.INTRA CELLULAR THERAPIES : Announces Closing of $460 Million Public Offering Including Ful..
07.01.Intra-Cellular Therapies Closes $460 Million Common Stock Offering
07.01.INTRA-CELLULAR THERAPIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K..
07.01.Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
05.01.INTRA CELLULAR THERAPIES : Information relating to Item 14 of the Registration Statement o..
05.01.INTRA CELLULAR THERAPIES : Financial Statements - Form 8-K
05.01.INTRA-CELLULAR THERAPIES, INC. : Entry into a Material Definitive Agreement, Other Events,..
05.01.INTRA-CELLULAR THERAPIES, INC. : Financial Statements and Exhibits (form 8-K)
05.01.Intra-Cellular Therapies Prices Common Stock Offering at $42 Per Share
05.01.Intra-Cellular Therapies Prices Public Offering of Common Stock
04.01.AFTER HOURS WATCH LIST SCORECARD : Lqda, itci, cnm
04.01.Health Care Stocks Stumble Through Weak Tuesday Session
04.01.Health Care Stocks Retreating Tuesday as Biotechs Sink
04.01.SECTOR UPDATE : Health Care
04.01.Health Care Stocks Mixed Pre-Bell Tuesday
04.01.Intra-Cellular Therapies Kicks off $400 Million Share Offering -- Stock Slumps in Pre-M..
04.01.INTRA CELLULAR THERAPIES : Announces Proposed Public Offering of Common Stock - Form 8-K
04.01.INTRA-CELLULAR THERAPIES, INC. : Results of Operations and Financial Condition, Other Even..
1  2  3  4  5  6  7  8Weiter
Anstehende Termine für INTRA-CELLULAR THERAPIES, INC.